These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

518 related articles for article (PubMed ID: 33568267)

  • 1. Prevalence of SARS-CoV-2 antibodies among North Dakota community pharmacy personnel: A seroprevalence survey.
    Johnson A; Vincent B; Carson P; Skoy E
    J Am Pharm Assoc (2003); 2021; 61(3):e127-e132. PubMed ID: 33568267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The seroprevalence of SARS-CoV-2 in a rural southwest community.
    Santarelli A; Lalitsasivimol D; Bartholomew N; Reid S; Reid J; Lyon C; Wells J; Ashurst J
    J Osteopath Med; 2021 Feb; 121(2):199-210. PubMed ID: 33567087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of SARS-CoV-2 antibodies among firefighters/paramedics of a US fire department: a cross-sectional study.
    Caban-Martinez AJ; Schaefer-Solle N; Santiago K; Louzado-Feliciano P; Brotons A; Gonzalez M; Issenberg SB; Kobetz E
    Occup Environ Med; 2020 Dec; 77(12):857-861. PubMed ID: 32764107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam.
    Hasan T; Pham TN; Nguyen TA; Le HTT; Van Le D; Dang TT; Van TD; Pham YN; Nguyen HV; Tran GL; Nguyen VTC; Nguyen TT; Truong VQ; Dao TH; Le CT; Truong NT; Vo HT; Le PT; Nguyen TT; Van Luu V; Nguyen VD; Toelle BG; Marks GB; Fox GJ
    Int J Environ Res Public Health; 2021 Jun; 18(12):. PubMed ID: 34208212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019-2021.
    Ssuuna C; Galiwango RM; Kankaka EN; Kagaayi J; Ndyanabo A; Kigozi G; Nakigozi G; Lutalo T; Ssekubugu R; Wasswa JB; Mayinja A; Nakibuuka MC; Jamiru S; Oketch JB; Muwanga E; Chang LW; Grabowski MK; Wawer M; Gray R; Anderson M; Stec M; Cloherty G; Laeyendecker O; Reynolds SJ; Quinn TC; Serwadda D
    BMC Infect Dis; 2022 Feb; 22(1):174. PubMed ID: 35189840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Seroprevalence of SARS-CoV-2 IgG antibodies and risk factors in health care workers at an academic medical center in Boston, Massachusetts.
    Kataria Y; Cole M; Duffy E; de la Cena K; Schechter-Perkins EM; Bouton TC; Werler MM; Pierre C; Ragan EJ; Weber SE; Jacobson KR; Andry C
    Sci Rep; 2021 May; 11(1):9694. PubMed ID: 33958668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cross-sectional study of SARS-CoV-2 seroprevalence among asymptomatic healthcare workers in a tertiary healthcare centre: Assessing the impact of PPE guidelines.
    Wattal C; Oberoi JK; Goel N; Datta S; Raveendran R; Rao BK; Kumar R
    Indian J Med Microbiol; 2021; 39(4):528-533. PubMed ID: 34688485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of SARS-CoV-2 antibodies in over 6000 healthcare workers in Spain.
    Varona JF; Madurga R; Peñalver F; Abarca E; Almirall C; Cruz M; Ramos E; Castellano Vázquez JM
    Int J Epidemiol; 2021 May; 50(2):400-409. PubMed ID: 33434269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distorted chemosensory perception and female sex associate with persistent smell and/or taste loss in people with SARS-CoV-2 antibodies: a community based cohort study investigating clinical course and resolution of acute smell and/or taste loss in people with and without SARS-CoV-2 antibodies in London, UK.
    Makaronidis J; Firman C; Magee CG; Mok J; Balogun N; Lechner M; Carnemolla A; Batterham RL
    BMC Infect Dis; 2021 Feb; 21(1):221. PubMed ID: 33632171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Seroprevalence in Healthcare Workers of Kaunas Hospitals during the First Wave of the COVID-19 Pandemic.
    Pereckaitė L; Dambrauskienė A; Urbonienė D; Sadauskas S; Petrikonis K; Naudžiūnas A; Vitkauskienė A
    Medicina (Kaunas); 2021 Feb; 57(2):. PubMed ID: 33562085
    [No Abstract]   [Full Text] [Related]  

  • 11. SARS-CoV-2 Seroprevalence Among Healthcare Workers by Workplace Exposure Risk in Kashmir, India.
    Khan MS; Haq I; Qurieshi MA; Majid S; Bhat AA; Qazi TB; Chowdri IN; Sabah I; Kawoosa MF; Lone AA; Nabi S; Sumji IA; Obaid M; Kousar R
    J Hosp Med; 2021 May; 16(5):274-281. PubMed ID: 33929947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antibody Screening and Risk Assessment of Healthcare Professionals in the COVID-19 Pandemic].
    Gümüş HH; Demiroğlu YZ; Alışkan HE; Ödemiş İ; Ceylan Ö; Poçan AG; Karagün Ö
    Mikrobiyol Bul; 2021 Jul; 55(3):357-373. PubMed ID: 34416802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel.
    Jacob JT; Baker JM; Fridkin SK; Lopman BA; Steinberg JP; Christenson RH; King B; Leekha S; O'Hara LM; Rock P; Schrank GM; Hayden MK; Hota B; Lin MY; Stein BD; Caturegli P; Milstone AM; Rock C; Voskertchian A; Reddy SC; Harris AD
    JAMA Netw Open; 2021 Mar; 4(3):e211283. PubMed ID: 33688967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [SARS-CoV-2 Seroprevalence Among Healthcare Workers: Retrospective Analysis of the Data From A University Hospital in Turkey].
    Özdemir A; Demir Çuha M; Telli Dizman G; Alp A; Metan G; Şener B
    Mikrobiyol Bul; 2021 Apr; 55(2):223-232. PubMed ID: 33882653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Anti-SARS-CoV-2 Specific Antibodies in Health-Care Workers Compared to General Population during an Early Phase of the Pandemic, Tehran-Iran.
    Mortezagholi S; Rostamzadeh D; Alinejad M; Younesi V; Tabarsi P; Shabani M
    Iran J Immunol; 2021 Mar; 18(1):82-92. PubMed ID: 33787517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [SARS-CoV-2 seroprevalence among workers in a hospital in Madrid.].
    Pérez-García F; Pérez-Zapata A; Arcos Varela N; de la Mata Herrera M; Ortiz García M; Simón Ramos E; Calero Barzano C; Clemente García B; García Miranda L; Martín Soto L; Ropero Martínez M; Barrabés Bayascas RM; Cuadros-González J
    Rev Esp Salud Publica; 2021 Oct; 95():. PubMed ID: 34675168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Seroprevalence of SARS-CoV-2 among Healthcare Workers in a North Italy Hospital.
    Airoldi C; Patrucco F; Milano F; Alessi D; Sarro A; Rossi MA; Cena T; Borrè S; Faggiano F
    Int J Environ Res Public Health; 2021 Mar; 18(7):. PubMed ID: 33804893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of SARS-CoV-2 Infection Evaluated by Immunochromatographic Rapid Testing for the Determination of IgM and IgG Against SARS-CoV-2 in a Cohort of Mask Wearing Workers in the Metal-Mechanical Sector in an Area With a High Incidence of COVID-19.
    Esposito S; Neglia C; Affanni P; Colucci ME; Argentiero A; Veronesi L; Messina G; Deolmi M; Principi N;
    Front Public Health; 2021; 9():628098. PubMed ID: 34249830
    [No Abstract]   [Full Text] [Related]  

  • 19. Seroprevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection among Veterans Affairs healthcare system employees suggests higher risk of infection when exposed to SARS-CoV-2 outside the work environment.
    Dimcheff DE; Schildhouse RJ; Hausman MS; Vincent BM; Markovitz E; Chensue SW; Deng J; McLeod M; Hagan D; Russell J; Bradley SF
    Infect Control Hosp Epidemiol; 2021 Apr; 42(4):392-398. PubMed ID: 32962771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of SARS-COV-2 positivity in 516 German intensive care and emergency physicians studied by seroprevalence of antibodies National Covid Survey Germany (NAT-COV-SURV).
    Kindgen-Milles D; Brandenburger T; Braun JFW; Cleff C; Moussazadeh K; Mrosewski I; Timm J; Wetzchewald D
    PLoS One; 2021; 16(4):e0248813. PubMed ID: 33831032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.